Atracurium Besylate 55150-0217-10
- Manufacturer
- Auromedics Pharma Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 8, 2015
- Listing Expires
- December 31, 2026
- Application
- ANDA206011
Need to source Atracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atracurium Besylate | 100 mg/10mL |
Drug Class
Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]
Selected Package
55150-0217-10Selected10 VIAL, MULTI-DOSE in 1 CARTON (55150-217-10) / 10 mL in 1 VIAL, MULTI-DOSE